Literature DB >> 1976013

Studies on the metabolism of glycolyl-CoA.

J Vamecq1, J P Draye, J H Poupaert.   

Abstract

Glycolyl-CoA can be formed during the course of the beta-oxidation by rat liver mitochondria of 4-hydroxybutyrate. The existence of this beta-oxidation has been previously supported by the occurrence of 4-hydroxybutyrate and its beta-oxidation catabolites in urine from patients with 4-hydroxybutyric aciduria, an inborn error of gamma-aminobutyric acid metabolism due to the deficiency of succinic semialdehyde dehydrogenase. The characteristics of the mitochondrial beta-oxidation of 4-hydroxybutyrate were, in rat liver, compared with those of the mitochondrial beta-oxidation of butyrate. The inhibition by malonate of the oxidation of 4-hydroxybutyrate was about twofold weaker than that of oxidation of butyrate, whereas both oxidations were abolished by preincubating the mitochondria with 1 mM valproic acid, a known inhibitor of mitochondrial beta-oxidation. Mitochondria from rat kidney cortex were demonstrated to catalyse, as previously shown for hepatic mitochondria, the carnitine-dependent oxidation of 12-hydroxylauroyl-CoA-omega-Hydroxymonocarboxylyl-CoAs are thus concluded to be precursors of glycolyl-CoA also in rat kidney cortex. In addition, 3-hydroxypyruvate was found to be a precursor of glycolyl-CoA, since it was oxidized by bovine heart pyruvate dehydrogenase with a cofactor requirement similar to that of pyruvate oxidation. Glycolyl-CoA was a substrate of carnitine acetyltransferase (pigeon breast muscle). Pig heart citrate synthase was capable of catalyzing the condensation of glycolyl-CoA with oxaloacetate. The product of this reaction induced low NADH production rates dependent on the addition of porcine heart aconitase and isocitrate dehydrogenase.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1976013     DOI: 10.1139/o90-125

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  10 in total

1.  Metabolism of vertebrate amino sugars with N-glycolyl groups: elucidating the intracellular fate of the non-human sialic acid N-glycolylneuraminic acid.

Authors:  Anne K Bergfeld; Oliver M T Pearce; Sandra L Diaz; Tho Pham; Ajit Varki
Journal:  J Biol Chem       Date:  2012-06-12       Impact factor: 5.157

2.  Catabolism of 4-hydroxyacids and 4-hydroxynonenal via 4-hydroxy-4-phosphoacyl-CoAs.

Authors:  Guo-Fang Zhang; Rajan S Kombu; Takhar Kasumov; Yong Han; Sushabhan Sadhukhan; Jianye Zhang; Lawrence M Sayre; Dale Ray; K Michael Gibson; Vernon A Anderson; Gregory P Tochtrop; Henri Brunengraber
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

Review 3.  Inherited disorders of GABA metabolism.

Authors:  C Jakobs; J Jaeken; K M Gibson
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

4.  A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence.

Authors:  H H Chou; H Takematsu; S Diaz; J Iber; E Nickerson; K L Wright; E A Muchmore; D L Nelson; S T Warren; A Varki
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

5.  Metabolism of vertebrate amino sugars with N-glycolyl groups: intracellular β-O-linked N-glycolylglucosamine (GlcNGc), UDP-GlcNGc, and the biochemical and structural rationale for the substrate tolerance of β-O-linked β-N-acetylglucosaminidase.

Authors:  Matthew S Macauley; Jefferson Chan; Wesley F Zandberg; Yuan He; Garrett E Whitworth; Keith A Stubbs; Scott A Yuzwa; Andrew J Bennet; Ajit Varki; Gideon J Davies; David J Vocadlo
Journal:  J Biol Chem       Date:  2012-06-12       Impact factor: 5.157

Review 6.  Involvement of a non-human sialic Acid in human cancer.

Authors:  Annie N Samraj; Heinz Läubli; Nissi Varki; Ajit Varki
Journal:  Front Oncol       Date:  2014-02-19       Impact factor: 6.244

7.  Antitumor effects of the GM3(Neu5Gc) ganglioside-specific humanized antibody 14F7hT against Cmah-transfected cancer cells.

Authors:  Denise Dorvignit; Kayluz F Boligan; Ernesto Relova-Hernández; Marilyn Clavell; Armando López; Mayrel Labrada; Hans-Uwe Simon; Alejandro López-Requena; Circe Mesa; Stephan von Gunten
Journal:  Sci Rep       Date:  2019-07-09       Impact factor: 4.379

Review 8.  Loss of N-glycolylneuraminic acid in humans: Mechanisms, consequences, and implications for hominid evolution.

Authors:  A Varki
Journal:  Am J Phys Anthropol       Date:  2001       Impact factor: 2.868

9.  Model-driven discovery of synergistic inhibitors against E. coli and S. enterica serovar Typhimurium targeting a novel synthetic lethal pair, aldA and prpC.

Authors:  Ramy K Aziz; Valerie L Khaw; Jonathan M Monk; Elizabeth Brunk; Robert Lewis; Suh I Loh; Arti Mishra; Amrita A Nagle; Chitkala Satyanarayana; Saravanakumar Dhakshinamoorthy; Michele Luche; Douglas B Kitchen; Kathleen A Andrews; Bernhard Ø Palsson; Pep Charusanti
Journal:  Front Microbiol       Date:  2015-09-23       Impact factor: 5.640

Review 10.  From "Serum Sickness" to "Xenosialitis": Past, Present, and Future Significance of the Non-human Sialic Acid Neu5Gc.

Authors:  Chirag Dhar; Aniruddha Sasmal; Ajit Varki
Journal:  Front Immunol       Date:  2019-04-17       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.